Inari: Inari Medical, Inc. Announces Partnership with American Venous Forum and National Blood Clot Alliance on DEFIANCE Trial

Inari Medical, Inc. announced collaborative partnerships with the American Venous Forum ("AVF") and the National Blood Clot Alliance ("NBCA") on the DEFIANCE trial. This prospective, multinational, randomized controlled trial ("RCT") will evaluate and compare clinical outcomes in patients with deep vein thrombosis ("DVT") treated with Inari's ClotTriever System versus anticoagulation alone. AVF is a non-profit society dedicated to improving the care of patients with venous and lymphatic disease, with members and leadership recognized internationally as thought leaders, expert investigators and top clinicians in the field. In collaboration with Inari, AVF will help create awareness of DEFIANCE and assist with the enrollment of this important trial through its members and stakeholders. NBCA is the leading non-profit in the United States focused on building awareness and community among people who are affected by blood clots.